Brief: Pyc Therapeutics Says Has Increased Its Shareholding In Vision Pharma
29/11/2022 01:32
Nov 29 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* HAS INCREASED ITS SHAREHOLDING IN VISION PHARMA TO 95.2%
* INCREASED SHAREHOLDING VIA A A$10 MILLION
RE-CAPITALISATION
Source text for Eikon: ID:nASX36TbtN
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsBrief: PYC Therapeutics Announces Grant Of Patents By The US Patent Office
Brief: PYC Therapeutics Appoints Chief Financial Officer
Australia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million